Home Authors Posts by Sonia Portillo

Sonia Portillo

127 POSTS 0 COMMENTS
Sonia Portillo is an associate editor of ADC Review/ Journal of Antibody-Drug Conjugates, an online, peer-reviewed publication dedicated to following the developments of ADCs and other targeted therapies. Portillo studies cancer treatment from a pharmacological perspective, specifically in the area of precision and personalized medicine.
Featured Image: Lonza, Visp, Switzerland. Courtesy: © 2010 - 2018 Lonza, Visp, Switzerland. Used with permission.

Lonza Expands Manufacturing Capacity for ADC Payloads

Sonia Portillo

Novartis Plans to Acquire Endocyte to Expand Expertise in Radiopharmaceuticals

Sonia Portillo

A New Generation of Precisely Engineered CD74-Targeting ADCs Receive Orphan Drug...

Sonia Portillo

NanoValent Receives NIH SBIR Funding for Ongoing Development of Antibody-conjugated Nanoparticle...

Sonia Portillo
WuXi Biologics. 1,000 LX2 disposable bioreactors for perfusion processes.

Single-layer Film Bags vs. Multi-layer Film Bags Biopharmaceutical Manufacturing

Sonia Portillo

New Reports Suggests Antibody-drug Conjugates Market to Set Phenomenal Growth in...

Sonia Portillo

A New Maytansinoid-Payload for Antibody-drug Conjugates Development

Sonia Portillo

PEGs and Antibody-drug Conjugates a Versatile Approach

Peter Hofland

Celldex Prioritizes Development Pipeline – Discontinues ADC-development Programs

Sonia Portillo
Featured Image: Laboratory Glass works. Courtesy: © 2010 - 2018. Fotolia Used with permission.

Study Shows Targeted ‘Click-to-release’ Chemotherapy Offers Positive Results in Mice

Sonia Portillo
123...13Page 1 of 13
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

MADE POSSIBLE BY
MabPlex

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.